{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:44:09Z","timestamp":1769762649642,"version":"3.49.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jaad.2015.05.040","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T01:22:19Z","timestamp":1445476939000},"page":"743-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Human papillomavirus vaccine trials and tribulations"],"prefix":"10.1016","volume":"73","author":[{"given":"Marc Z.","family":"Handler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy S.","family":"Handler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slawomir","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2015.05.040_bib1","unstructured":"Centers for Disease Control and Prevention website. HPV vaccine information for clinicians\u2013fact sheet. July 8, 2012. Available at: http:\/\/www.cdc.gov\/std\/hpv\/stdfact-hpv-vaccine-hcp.htm. Accessed July 25, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib2","unstructured":"Centers for Disease Control and Prevention website. HPV vaccine\u2013questions & answers. August 6, 2014. Available at: http:\/\/www.cdc.gov\/vaccines\/vpd-vac\/hpv\/vac-faqs.htm. Accessed July 25, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib3","unstructured":"Centers for Disease Control and Prevention website. Incidence, prevalence, and cost of sexually transmitted infections in the United States. Available at: http:\/\/www.cdc.gov\/std\/stats\/STI-Estimates-Fact-Sheet-Feb-2013.pdf. Access July 25, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11904-014-0224-x","article-title":"HPV and anal cancer in HIV-infected individuals: a review","volume":"11","author":"Schim van der Loeff","year":"2014","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jaad.2015.05.040_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00186418","article-title":"Invasive squamous-cell carcinoma in giant anorectal condyloma (Buschke\u2013Lowenstein tumor)","volume":"380","author":"Bertram","year":"1995","journal-title":"Langenbecks Arch Chir"},{"key":"10.1016\/j.jaad.2015.05.040_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00430-002-0172-8","article-title":"Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod","volume":"192","author":"Wenzel","year":"2003","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.jaad.2015.05.040_bib8","first-page":"445","article-title":"Giant condyloma acuminatum - Buschke\u2013Lowenstein disease\u2013a literature review","volume":"109","author":"Spinu","year":"2014","journal-title":"Chirurgia (Bucur)"},{"key":"10.1016\/j.jaad.2015.05.040_bib9","unstructured":"National Cancer Institute website. Human papillomavirus (HPV) vaccines. Available at: http:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-vaccine-fact-sheet. Accessed July 25, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib10","unstructured":"Centers for Disease Control and Prevention. ACIP meeting HPV Luxembourg. Vaccines 2013. Available at: http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-oct-2013\/03-HPV-Luxembourg.pdf. Published 2013."},{"key":"10.1016\/j.jaad.2015.05.040_bib11","unstructured":"US Department of Health and Human Services, US Food and Drug Administration website. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm426485.htm. Accessed July 25, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib12","unstructured":"US Preventive Services Task Force website. Cervical cancer: screening. Available at: http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/UpdateSummaryFinal\/cervical-cancer-screening. Accessed July 25, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.aogh.2014.09.014","article-title":"Screening for cancer in low- and middle-income countries","volume":"80","author":"Sankaranarayanan","year":"2014","journal-title":"Ann Global Health"},{"issue":"21 suppl","key":"10.1016\/j.jaad.2015.05.040_bib14","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ygyno.2008.01.003","article-title":"The disparity of cervical cancer in diverse populations","volume":"109","author":"Downs","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaad.2015.05.040_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/msj.20263","article-title":"Cervical cancer screening in low- and middle-income countries","volume":"78","author":"Ditzian","year":"2011","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.jaad.2015.05.040_bib16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.AOG.0000159549.56601.75","article-title":"Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women","volume":"105","author":"Benard","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2015.05.040_bib17","first-page":"248","article-title":"Factors associated with no surgery or radiation therapy for invasive cervical cancer in black and white women","volume":"10","author":"Merrill","year":"2000","journal-title":"Ethn Dis"},{"issue":"suppl 5","key":"10.1016\/j.jaad.2015.05.040_bib18","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2015.05.040_bib19","unstructured":"Centers for Disease Control and Prevention. Genital HPV Infection\u2013Fact Sheet. Human Papillomavirus (HPV): Centers for Disease Control and Prevention; 2014. Available at: http:\/\/www.cdc.gov\/std\/hpv\/hpv-factsheet-march-2014.pdf. Published January 23, 2014."},{"key":"10.1016\/j.jaad.2015.05.040_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":"Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006","volume":"204","author":"Hariri","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib21","unstructured":"Centers for Disease Control and Prevention website. How many cancers are linked with HPV each year? Available at: http:\/\/www.cdc.gov\/cancer\/hpv\/statistics\/cases.htm. Accessed July 22, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib22","first-page":"258","article-title":"Human papillomavirus\u2013associated cancers\u2013United States, 2004-2008","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaad.2015.05.040_bib23","unstructured":"HPV Center. Human Papillomavirus and Related Diseases Report 2014. Available at: http:\/\/www.hpvcentre.net\/summaryreport.php. Published December 18, 2014."},{"key":"10.1016\/j.jaad.2015.05.040_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.11334","article-title":"A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16\/18 vaccine","volume":"106","author":"Goldie","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2015.05.040_bib25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2147\/IJWH.S49471","article-title":"New molecular targets against cervical cancer","volume":"6","author":"Duenas-Gonzalez","year":"2014","journal-title":"Int J Women's Health"},{"key":"10.1016\/j.jaad.2015.05.040_bib26","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D'Souza","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.05.040_bib27","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/ijc.22177","article-title":"Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer","volume":"119","author":"Hammarstedt","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2015.05.040_bib28","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2015.05.040_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1368-8375(99)00070-6","article-title":"Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues","volume":"36","author":"Franceschi","year":"2000","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaad.2015.05.040_bib30","doi-asserted-by":"crossref","first-page":"e115931","DOI":"10.1371\/journal.pone.0115931","article-title":"Human papillomavirus prevalence in invasive laryngeal cancer in the United States","volume":"9","author":"Hernandez","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaad.2015.05.040_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2015.05.040_bib32","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jadohealth.2008.07.002","article-title":"Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination","volume":"43","author":"Gillison","year":"2008","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jaad.2015.05.040_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10006-012-0383-0","article-title":"The role of human papillomavirus in oral squamous cell carcinoma: myth and reality","volume":"18","author":"Kansy","year":"2014","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.jaad.2015.05.040_bib34","doi-asserted-by":"crossref","unstructured":"Strojan P, Zadnik V, Sifrer R, et al. Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection. Eur Arch Otorhinolaryngol. doi: http:\/\/dx.doi.org\/10.1007\/s00405-014-3459-7. Published online December 27, 2014.","DOI":"10.1007\/s00405-014-3459-7"},{"key":"10.1016\/j.jaad.2015.05.040_bib35","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/cncr.23744","article-title":"Understanding the burden of human papillomavirus-associated anal cancers in the US","volume":"113","author":"Joseph","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2015.05.040_bib36","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"issue":"suppl 5","key":"10.1016\/j.jaad.2015.05.040_bib37","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","article-title":"Updating the natural history of human papillomavirus and anogenital cancers","volume":"30","author":"Moscicki","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2015.05.040_bib38","doi-asserted-by":"crossref","unstructured":"Prendes BL, Wang SJ, Groppo ER, Eisele DW, Palefsky JM. Oral human papillomavirus infection in men who have sex with men with anal squamous intraepithelial lesions. Head Neck.\u00a0http:\/\/dx.doi.org\/10.1002\/hed.24006. Published online January 12, 2015.","DOI":"10.1002\/hed.24006"},{"key":"10.1016\/j.jaad.2015.05.040_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/s12879-014-0671-4","article-title":"Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men","volume":"14","author":"Mendez-Martinez","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(12)70080-3","article-title":"Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis","volume":"13","author":"Machalek","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2015.05.040_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2407-12-30","article-title":"Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review","volume":"12","author":"Hartwig","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jaad.2015.05.040_bib42","first-page":"101","article-title":"Human papillomavirus, genital warts, and vaccines","volume":"42","author":"Hsueh","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jaad.2015.05.040_bib43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1471-2334-10-360","article-title":"Incidence of anogenital warts in Germany: a population-based cohort study","volume":"10","author":"Kraut","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/eurpub\/ckn127","article-title":"Epidemiology and cost of treatment of genital warts in Spain","volume":"19","author":"Castellsague","year":"2009","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.jaad.2015.05.040_bib45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/OLQ.0b013e318198de8c","article-title":"Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada","volume":"36","author":"Kliewer","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/sti.2008.030999","article-title":"Epidemiology and costs associated with genital warts in Canada","volume":"85","author":"Marra","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jaad.2015.05.040_bib47","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.lpm.2014.10.001","article-title":"HPV in genital cancers (at the exception of cervical cancer) and anal cancers","volume":"43","author":"de Sanjose","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.jaad.2015.05.040_bib48","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-14-1656","article-title":"Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer","volume":"21","author":"Feber","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2015.05.040_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fonc.2014.00009","article-title":"Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population","volume":"4","author":"Hernandez","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaad.2015.05.040_bib50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma","volume":"62","author":"Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaad.2015.05.040_bib51","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/ijc.23707","article-title":"Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation","volume":"123","author":"Kalantari","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2015.05.040_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.AOG.0000266984.23445.9c","article-title":"Sociodemographic factors associated with high-risk human papillomavirus infection","volume":"110","author":"Kahn","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2015.05.040_bib53","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1158\/1055-9965.EPI-14-0386","article-title":"Sexual Transmission of Oral Human Papillomavirus Infection among Men","volume":"23","author":"Dahlstrom","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2015.05.040_bib54","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/OLQ.0000000000000159","article-title":"Sexual behaviors and other risk factors for oral human papillomavirus infections in young women","volume":"41","author":"Cook","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib55","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit018","article-title":"Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals","volume":"207","author":"Widdice","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib56","doi-asserted-by":"crossref","first-page":"19662","DOI":"10.7448\/IAS.17.4.19662","article-title":"Prevalence of anal human papillomavirus infection and cytologic abnormalities among HIV-infected and HIV-uninfected men who have sex with men","volume":"17","author":"Latini","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jaad.2015.05.040_bib57","doi-asserted-by":"crossref","first-page":"e84030","DOI":"10.1371\/journal.pone.0084030","article-title":"Risk Factors for the presence of anal intraepithelial neoplasia in HIV+ men who have sex with men","volume":"8","author":"Richel","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jaad.2015.05.040_bib58","unstructured":"American Cancer Society. Do we know what causes anal cancer? Anal Cancer 2014. Available at: http:\/\/www.cancer.org\/cancer\/analcancer\/detailedguide\/anal-cancer-what-causes. Published May 2, 2014."},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2015.05.040_bib59","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2015.05.040_bib60","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2334-14-312","article-title":"The potential impact of HPV-16 reactivation on prevalence in older Australians","volume":"14","author":"Korostil","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib61","unstructured":"National Cancer Institute. HPV and Cancer. Cancer Topics2012. Available at: http:\/\/www.cancer.gov\/cancertopics\/factsheet\/Risk\/HPV#r1. Published March 15, 2012."},{"key":"10.1016\/j.jaad.2015.05.040_bib62","series-title":"Abeloff's clinical oncology","author":"Niederhuber","year":"2014"},{"key":"10.1016\/j.jaad.2015.05.040_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/135965350200700401","article-title":"Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches","volume":"7","author":"Bernard","year":"2002","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jaad.2015.05.040_bib64","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/jvi.68.2.619-625.1994","article-title":"Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence","volume":"68","author":"Zhou","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.jaad.2015.05.040_bib65","doi-asserted-by":"crossref","first-page":"e101576","DOI":"10.1371\/journal.pone.0101576","article-title":"Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaad.2015.05.040_bib66","article-title":"Site of infections associated with human papillomavirus","author":"Beltrao","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jaad.2015.05.040_bib67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/scbi.1999.0141","article-title":"Human papillomavirus life cycle: active and latent phases","volume":"9","author":"Stubenrauch","year":"1999","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jaad.2015.05.040_bib68","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2015.05.040_bib69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.11691","article-title":"Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins","volume":"109","author":"Duensing","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2015.05.040_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jchromb.2014.12.004","article-title":"Optimization of supercoiled HPV-16 E6\/E7 plasmid DNA purification with arginine monolith using design of experiments","volume":"978-979","author":"Almeida","year":"2014","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jaad.2015.05.040_bib71","doi-asserted-by":"crossref","first-page":"689","DOI":"10.5578\/mb.7631","article-title":"[Current problems and recent advances in the molecular diagnosis of genital human papillomavirus infections]","volume":"48","author":"Sahiner","year":"2014","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.jaad.2015.05.040_bib72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virol.2014.08.022","article-title":"SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6\/E7 promoter","volume":"468-470","author":"Smith","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.jaad.2015.05.040_bib73","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<16::AID-IJC3>3.0.CO;2-4","article-title":"Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions","volume":"73","author":"Malejczyk","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2015.05.040_bib74","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.vaccine.2013.10.081","article-title":"HPV vaccines to prevent cervical cancer and genital warts: an update","volume":"32","author":"Dochez","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2015.05.040_bib75","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/erv.12.42","article-title":"Cervarix(R): a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types","volume":"11","author":"Szarewski","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jaad.2015.05.040_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/120347540200600204","article-title":"Extragenital bowenoid papulosis associated with atypical human papillomavirus genotypes","volume":"6","author":"Papadopoulos","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2015.05.040_bib77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpag.2013.04.002","article-title":"Counseling about the HPV vaccine: desexualize, educate, and advocate","volume":"26","author":"Grimes","year":"2013","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jaad.2015.05.040_bib78","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1016\/j.vaccine.2013.06.057","article-title":"Quadrivalent HPV\u00a0vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males","volume":"31","author":"Goldstone","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2015.05.040_bib79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/CVI.05208-11","article-title":"Immunogenicity of the quadrivalent human papillomavirus (type 6\/11\/16\/18) vaccine in males 16 to 26 years old","volume":"19","author":"Hillman","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaad.2015.05.040_bib80","unstructured":"Administration UFaD. FDA: Gardasil approved to prevent anal cancer. In: S. Burgess editor. News & Events. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm237941.htm. Accessed August 6, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib81","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jaad.2015.05.040_bib82","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jaad.2015.05.040_bib83","unstructured":"Merck. Patient Information about GARDASIL\u00ae92014. Available at: http:\/\/www.merck.com\/product\/usa\/pi_circulars\/g\/gardasil_9\/gardasil_9_ppi.pdf. Published December 10, 2014."},{"issue":"suppl","key":"10.1016\/j.jaad.2015.05.040_bib84","doi-asserted-by":"crossref","first-page":"40470","DOI":"10.1155\/IDOG\/2006\/40470","article-title":"Epidemiology and natural history of human papillomavirus infections in the female genital tract","volume":"2006","author":"Ault","year":"2006","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jaad.2015.05.040_bib85","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/88.19.1361","article-title":"Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer","volume":"88","author":"Burger","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2015.05.040_bib86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1055-9965.EPI-14-0649","article-title":"HPV type attribution in high grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States","volume":"24","author":"Hariri","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2015.05.040_bib87","unstructured":"Adminstration UFaD. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. FDA News Release FDA; 2014. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm426485.htm. Published December 10, 2014."},{"issue":"suppl 5","key":"10.1016\/j.jaad.2015.05.040_bib88","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1016\/j.vaccine.2012.05.091","article-title":"Therapy of human papillomavirus-related disease","volume":"30","author":"Stern","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2015.05.040_bib89","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1586\/14760584.2014.935767","article-title":"Alternative dosage schedules with HPV virus-like particle vaccines","volume":"13","author":"Stanley","year":"2014","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.jaad.2015.05.040_bib90","doi-asserted-by":"crossref","first-page":"g7584","DOI":"10.1136\/bmj.g7584","article-title":"Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model","volume":"350","author":"Jit","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2015.05.040_bib91","unstructured":"Sante et Services Sociaux Quebec. Human Papillomavirus Viruses (HPV): Quebec; 2013."},{"key":"10.1016\/j.jaad.2015.05.040_bib92","series-title":"Change in schedule from three to two doses in the HPV vaccination programme","year":"2014"},{"key":"10.1016\/j.jaad.2015.05.040_bib93","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1158\/1055-9965.EPI-06-0041","article-title":"Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study","volume":"15","author":"Waller","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2015.05.040_bib94","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.2012-1516","article-title":"Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds","volume":"130","author":"Bednarczyk","year":"2012","journal-title":"Pediatrics"},{"issue":"suppl 4","key":"10.1016\/j.jaad.2015.05.040_bib95","first-page":"1","article-title":"Youth risk behavior surveillance\u2014United States, 2013","volume":"63","author":"Kann","year":"2014","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.jaad.2015.05.040_bib96","unstructured":"Institute of Education Sciences website. Trends in the prevalence of selected risk behaviors and obesity for all students national YRBS: 1991-2011. Available at: http:\/\/files.eric.ed.gov\/fulltext\/ED532809.pdf. Accessed July 25, 2015."},{"key":"10.1016\/j.jaad.2015.05.040_bib97","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amepre.2011.09.024","article-title":"Human papillomavirus vaccine and sexual behavior among adolescent and young women","volume":"42","author":"Liddon","year":"2012","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jaad.2015.05.040_bib98","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1542\/peds.2013-2822","article-title":"Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents","volume":"133","author":"Mayhew","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2015.05.040_bib99","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ypmed.2010.11.006","article-title":"Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008","volume":"52","author":"Taylor","year":"2011","journal-title":"Prev Med"},{"key":"10.1016\/j.jaad.2015.05.040_bib100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.contraception.2009.02.014","article-title":"Age of sexual debut among US adolescents","volume":"80","author":"Cavazos-Rehg","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2015.05.040_bib101","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.whi.2010.11.007","article-title":"The paradox of HPV vaccines: how to reach sexually inexperienced women for protection against a sexually transmitted infection","volume":"21","author":"Baxter","year":"2011","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.jaad.2015.05.040_bib102","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaad.2015.05.040_bib103","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial","volume":"373","author":"Munoz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2015.05.040_bib104","doi-asserted-by":"crossref","first-page":"g5789","DOI":"10.1136\/bmj.g5789","article-title":"Time to vaccinate boys against HPV infection and cancer, say parliamentarians with special interest in public health","volume":"349","author":"Baron","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2015.05.040_bib105","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/OLQ.0b013e318181294b","article-title":"Heterosexual anal sex activity in the year after an STD clinic visit","volume":"35","author":"Tian","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib106","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/OLQ.0b013e31822154f9","article-title":"The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study","volume":"38","author":"Nyitray","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib107","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2015.05.040_bib108","first-page":"312","article-title":"Management of external genital warts","volume":"90","author":"Karnes","year":"2014","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2015.05.040_bib109","doi-asserted-by":"crossref","first-page":"e92208","DOI":"10.1371\/journal.pone.0092208","article-title":"Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIV-negative men who have sex with men","volume":"9","author":"van Rijn","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaad.2015.05.040_bib110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/jiq015","article-title":"External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents","volume":"203","author":"Vardas","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib111","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.urology.2004.09.031","article-title":"Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection","volume":"65","author":"Nicolau","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.jaad.2015.05.040_bib112","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2105\/AJPH.2014.302095","article-title":"Human papillomavirus vaccination among young adult gay and bisexual men in the United States","volume":"105","author":"Reiter","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jaad.2015.05.040_bib113","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/95.14.1062","article-title":"Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women","volume":"95","author":"Strickler","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2015.05.040_bib114","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/cid\/ciu238","article-title":"Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women","volume":"59","author":"Kojic","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1529-8019.2010.01350.x","article-title":"An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention","volume":"23","author":"Forcier","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2015.05.040_bib116","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/bjs.7218","article-title":"Human papillomavirus infection and anal dysplasia in renal transplant recipients","volume":"97","author":"Patel","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.jaad.2015.05.040_bib117","first-page":"59","article-title":"Ano-genital neoplasia in renal transplant patients","volume":"2","author":"Sillman","year":"1997","journal-title":"Ann Transplant"},{"key":"10.1016\/j.jaad.2015.05.040_bib118","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/tri.12339","article-title":"Initial prevalence of anal human papilloma virus infection in liver transplant recipients","volume":"27","author":"Grat","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2015.05.040_bib119","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jadohealth.2014.04.015","article-title":"Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010","volume":"55","author":"Laugesen","year":"2014","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jaad.2015.05.040_bib120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jpag.2007.03.101","article-title":"The HPV vaccine mandate controversy","volume":"20","author":"Haber","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jaad.2015.05.040_bib121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/josh.12126","article-title":"Print news coverage of school-based human papillomavirus vaccine mandates","volume":"84","author":"Casciotti","year":"2014","journal-title":"J School Health"},{"key":"10.1016\/j.jaad.2015.05.040_bib122","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMp068248","article-title":"The ethics and politics of compulsory HPV vaccination","volume":"355","author":"Colgrove","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.05.040_bib123","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/339192","article-title":"Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs","volume":"185","author":"Goldstein","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib124","first-page":"29","article-title":"HPV viral load determination during pregnancy as a possible cervical cancer risk","volume":"25","author":"Bandyopadhyay","year":"2006","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jaad.2015.05.040_bib125","first-page":"529","article-title":"The occurrence of genital types of human papillomavirus in normal pregnancy and in pregnant renal transplant recipients","volume":"27","author":"Gajewska","year":"2006","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.jaad.2015.05.040_bib126","first-page":"766","article-title":"The occurrence of genital types of human papillomavirus in normal pregnancy and in pregnant women with pregestational insulin dependent diabetes mellitus","volume":"26","author":"Gajewska","year":"2005","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.jaad.2015.05.040_bib127","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0029-7844(97)00593-0","article-title":"Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery","volume":"91","author":"Tseng","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2015.05.040_bib128","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MOO.0b013e328316930e","article-title":"Recurrent respiratory papillomatosis: update 2008","volume":"16","author":"Gallagher","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaad.2015.05.040_bib129","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/infdis\/jit611","article-title":"A case for immunization of human papillomavirus (HPV) 6\/11-infected pregnant women with the quadrivalent HPV vaccine to prevent juvenile-onset laryngeal papilloma","volume":"209","author":"Shah","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/OLQ.0000000000000115","article-title":"Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States","volume":"41","author":"Marsico","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2015.05.040_bib131","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","article-title":"Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States","volume":"30","author":"Chesson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2015.05.040_bib132","series-title":"Gardasil [package insert]","year":"2011"},{"key":"10.1016\/j.jaad.2015.05.040_bib133","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/AOG.0b013e3181c2ca21","article-title":"Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6\/11\/16\/18 vaccine: a combined analysis of five randomized controlled trials","volume":"114","author":"Garland","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2015.05.040_bib134","series-title":"Cervarix [package insert]","year":"2009"},{"key":"10.1016\/j.jaad.2015.05.040_bib135","unstructured":"Merck & Co. Merck's Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study 2013."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221501748X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221501748X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:36:34Z","timestamp":1759271794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221501748X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":135,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S019096221501748X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.05.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus vaccine trials and tribulations","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(15)02215-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}